Area: Strategy
How Medical Device Makers Reacted to Publication of a Once-Secret Database of Millions of Adverse Events
New product filings to FDA included stronger safety features and larger technological advances
How Established Firms Get Disrupted by Allies
Suppliers, distributers, product extenders go from helper to competitor
How Diversified Companies Can Redeploy Workers to Enable Growth
Experienced hands help new business lines find their way
How Antitrust Thinking on Hospital Mergers Has Been Forced to Evolve
Matt Schmitt’s research shows hospital prices rise after acquisitions, even where local competition is unchanged
Household Waste Reduction Gets a Lot of Study — But Institutional Settings Are the Bigger Opportunities
Growing tension between behavioral research focused on the individual and the study of societal systems
Household Energy Efficiency: Not All Upgrades Are Created Equal
Behavior, other factors influence which improvements are effective
Has the Term ‘Competitive Advantage’ Outlived Its Usefulness?
Popular in business schools and executive suites, it’s no longer a meaningful way to compare companies
Gaining Status in an Online Community
How unknown individuals turn into influencers on a platform for programmers
Founding a Substantial Business Builds Wealth, But Those Who Aren’t Born Well-to-Do Seldom Attempt It
The few born into poor families who own an incorporated business see wealth gains similar to entrepreneurs from privileged backgrounds
For New College Grads, the AI Jobpocalypse Didn’t Arrive
Even counting grads who want a job but aren’t looking, summer 2026 looked like other recent summers
FDA’s Breakthrough Program: Faster Drug OKs Without Sacrificing Safety
Dedicated FDA staff guide companies during design of clinical trials
Face-to-Face Meetings, Before an Acquisition, Improve Outcomes for Buyers
Acquiring companies appear to get a better deal following frequent in-person meetings
Exploring the Relationship between Off-Label Prescriptions and Clinical Trials
A study looks at how changes in FDA labeling affect pediatric utilization of drugs
Exploiting Regulatory Loophole Speeds Cancer Drug Development
Pharma companies seek OK for limited use, then expand sales through off-label prescribing, saving millions
Entrepreneurship, Riskier in Wealthy Nations, Is Actually Safer in India
Steady employment is rare — a condition some U.S. workers also endure
Ending Greenwashing Requires an Understanding of Its Origins
Foundational research broadened the conversation from intentional deception to include outcomes of external pressures, organizational systems, and human bias